Time-course characterization of the computed tomography contrast enhancement of an iodinated blood-pool contrast agent in mice using a volumetric flat-panel equipped computed tomography scanner

Investigative Radiology
N L FordD W Holdsworth

Abstract

The objective of this study was to determine the time-course of computed tomography (CT) contrast enhancement of an iodinated blood-pool contrast agent. Five C57BL/6 mice were anesthetized, imaged at baseline, and given an iodinated blood-pool contrast agent. Micro-CT scans were acquired at 0, 0.25, 0.5, 1, 2, 4, 8, and 24 hours after injection. The mean CT number was determined in a region of interest in 7 organs. The CT contrast enhancement was plotted as a function of time for each organ. We identified an imaging window immediately after injection suitable for visualizing the vascular system and a second imaging window at 24 hours for visualizing liver and spleen. A single injection of the blood-pool contrast agent can be used for dual-phase investigations of the vasculature (t = 0 hours) and liver (t = 24 hours), which can be applied to studies of liver tumors or disease.

References

Apr 30, 1998·Academic Radiology·J P WeichertR E Counsell
May 5, 1999·Investigative Radiology·R FischbachK Lackner
Jul 26, 2002·Academic Radiology·David R Vera, Robert F Mattrey
May 21, 2003·Academic Radiology·Chen-Yu KaoAnanth V Annapragada
Oct 21, 2003·Investigative Radiology·Christoph R BeckerMaximilian F Reiser
May 15, 2004·Molecular Imaging·Dawn CavanaughDianna D Cody
Jul 17, 2004·Annual Review of Biomedical Engineering·Erik L Ritman
Jul 20, 2004·Journal of Computer Assisted Tomography·Alessandro NapoliGeoffrey D Rubin
Oct 9, 2004·Physics in Medicine and Biology·Erin B WaltersDianna D Cody
Nov 9, 2004·Molecular Imaging·John M BooneSimon R Cherry
Jan 18, 2005·Medical Physics·C BadeaG A Johnson
Apr 15, 2005·Investigative Radiology·Dianna D CodyJonathan M Kurie
Nov 4, 2005·Medical Physics·Nancy L FordDavid W Holdsworth

❮ Previous
Next ❯

Citations

Jul 31, 2013·Pharmaceutical Research·Nicolas Anton, Thierry F Vandamme
Dec 11, 2008·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Inneke WillekensJohan de Mey
Mar 28, 2008·Physics in Medicine and Biology·Youngho SeoBruce H Hasegawa
Sep 2, 2008·Physics in Medicine and Biology·C T BadeaG A Johnson
Oct 13, 2011·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Arvind ChopraAnne Menkens
Dec 6, 2012·Chemical Reviews·Hrvoje Lusic, Mark W Grinstaff
Jan 22, 2008·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Chris E Suckow, David B Stout
Jan 4, 2008·ILAR Journal·Isabel J HildebrandtWolfgang A Weber
Jan 4, 2008·ILAR Journal·Kennita Johnson
Jan 27, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Suyeon YouYoonkyung Kim
Jun 1, 2010·Biomaterials·François HallouardThierry Vandamme
Jul 19, 2008·Biomaterials·Robert E GuldbergMarc E Levenston
Mar 22, 2012·Contrast Media & Molecular Imaging·Sarah A DetombeMaria Drangova
Mar 19, 2016·Contrast Media & Molecular Imaging·Julia G MannheimBernd J Pichler
Jul 4, 2012·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Fang-Yi LoYi-Ching Wang
Dec 23, 2017·Contrast Media & Molecular Imaging·Justin J TseDavid W Holdsworth
Mar 18, 2009·Tissue Engineering. Part C, Methods·William Lafayette MondyLes A Piegl
Apr 21, 2007·Contrast Media & Molecular Imaging·M AlmajdubM Janier
Sep 21, 2007·Physics in Medicine and Biology·Nancy L FordMaria Drangova
Nov 22, 2007·Physics in Medicine and Biology·Louise Y DuDavid W Holdsworth
Dec 17, 2010·Physics in Medicine and Biology·W Kyle Foster, Nancy L Ford
Oct 6, 2006·Expert Review of Anticancer Therapy·Ian C MacDonald, Ann F Chambers
Jul 18, 2015·World Journal of Gastroenterology : WJG·Xiang-Wei HuaQiang Xia
Jan 14, 2021·Biomedical Physics & Engineering Express·Samir El Ketara, Nancy Lee Ford

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.